×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
A – agilent technologies, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
A
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
06:45 pm
a
How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch [Yahoo! Finance]
Low
Report
How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch [Yahoo! Finance]
4/1
04:19 pm
a
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents [Yahoo! Finance]
Low
Report
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents [Yahoo! Finance]
4/1
09:17 am
a
Infection Control Market Size Outlook 2026-2031: In-House Programs Dominate Service Delivery Mode with 53.40% Share, Reports Mordor Intelligence [TheStreet.com]
Low
Report
Infection Control Market Size Outlook 2026-2031: In-House Programs Dominate Service Delivery Mode with 53.40% Share, Reports Mordor Intelligence [TheStreet.com]
4/1
08:00 am
a
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader
Low
Report
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader
3/27
10:23 am
a
Is It Time To Consider Buying Agilent Technologies, Inc. (NYSE:A)? [Yahoo! Finance]
Low
Report
Is It Time To Consider Buying Agilent Technologies, Inc. (NYSE:A)? [Yahoo! Finance]
3/26
08:00 am
a
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
Low
Report
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
3/24
11:12 am
a
Agilent Technologies (A) to Acquire Biocare Medical for $950M [Yahoo! Finance]
Low
Report
Agilent Technologies (A) to Acquire Biocare Medical for $950M [Yahoo! Finance]
3/23
07:00 pm
a
Q4 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks [Yahoo! Finance]
Low
Report
Q4 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/24/2025
04:10 pm
a
agilent technologies, inc.
IN-LINE
Report
3.1%
agilent technologies, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/6
06:01 am
a
Form 8-K/A AGILENT TECHNOLOGIES, For: Mar 31
Low
Report
Form 8-K/A AGILENT TECHNOLOGIES, For: Mar 31
4/3
04:05 pm
a
Form 8-K AGILENT TECHNOLOGIES, For: Mar 31
Low
Report
Form 8-K AGILENT TECHNOLOGIES, For: Mar 31
4/2
04:07 pm
a
Form 4 AGILENT TECHNOLOGIES, For: Mar 31 Filed by: Henson Meghan
Low
Report
Form 4 AGILENT TECHNOLOGIES, For: Mar 31 Filed by: Henson Meghan
3/26
03:12 pm
a
Form SCHEDULE 13G/A AGILENT TECHNOLOGIES, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A AGILENT TECHNOLOGIES, Filed by: VANGUARD GROUP INC
3/23
04:39 pm
a
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: Rataj Sue H.
Low
Report
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: Rataj Sue H.
3/23
04:36 pm
a
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: BRAWLEY OTIS W
Low
Report
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: BRAWLEY OTIS W
3/23
04:30 pm
a
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: SCANGOS GEORGE A
Low
Report
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: SCANGOS GEORGE A
3/23
04:27 pm
a
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: Soriot Pascal
Low
Report
Form 4 AGILENT TECHNOLOGIES, For: Mar 19 Filed by: Soriot Pascal
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/14
Q3/2019 7/31/2019 EPS 0.760 ZacksConsensus 0.720 ActVsEst 0.040 - Beat
6.1%
11/26 Agilent Technologies Inc (NYSE: A) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $90.00. They now have an "overweight" rating on the stock. 4.6%
4/28 Form 4 AGILENT TECHNOLOGIES, For: Apr 27 Filed by: McMullen Michael R. 4.5%
3/2 Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions 3.8%
9/4 Form 4 AGILENT TECHNOLOGIES For: Aug 30 Filed by: FIELDS HEIDI 3.8%
3/18 Form DEFA14A AGILENT TECHNOLOGIES, 3.6%
4/14 Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21 3.4%
3/3 Form 10-Q AGILENT TECHNOLOGIES, For: Jan 31 3.3%
3/30 Agilent Announces New Class 1 Triple Quadrupole LC/MS System 2.8%
12/12 Leak Detection Associates Announces New SIMS 1915+ Low Temperature -80C Helium Leak Testing System 2.8%
11/26 Agilent Technologies Inc (NYSE: A) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $90.00. They now have an "overweight" rating on the stock. 4.6%
4/28 Form 4 AGILENT TECHNOLOGIES, For: Apr 27 Filed by: McMullen Michael R. 4.5%
3/2 Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions 3.8%
9/4 Form 4 AGILENT TECHNOLOGIES For: Aug 30 Filed by: FIELDS HEIDI 3.8%
3/18 Form DEFA14A AGILENT TECHNOLOGIES, 3.6%
4/14 Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21 3.4%
3/3 Form 10-Q AGILENT TECHNOLOGIES, For: Jan 31 3.3%
3/30 Agilent Announces New Class 1 Triple Quadrupole LC/MS System 2.8%
12/12 Leak Detection Associates Announces New SIMS 1915+ Low Temperature -80C Helium Leak Testing System 2.8%
TOP News Decliners
5/14
Q2/2019 4/30/2019 EPS 0.710 ZacksConsensus 0.720 ActVsEst (0.010) - Miss
-11.0%
4/20 Form 8-K AGILENT TECHNOLOGIES, For: Apr 17 -4.7%
3/4 Form DEFA14A AGILENT TECHNOLOGIES, -4.6%
3/18 Agilent Technologies Announces Cash Dividend of 18 Cents Per Share -4.5%
2/24 Agilent Technologies Inc (NYSE: A) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating. -4.2%
5/7 Agilent Announces Unique Portfolio to Advance Immunotherapy -3.4%
1/29 Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics -3.3%
4/30 Agilent Technologies Inc (NYSE: A) had its price target lowered by analysts at Cfra from $57.00 to $39.00. They now have a "hold" rating on the stock. -3.2%
8/9 Agilent Technologies Hitting Lower Rail Of Upwardly Sloped Trend Channel Ahead Of Earnings [Seeking Alpha] -2.9%
7/11 Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment -2.8%
4/20 Form 8-K AGILENT TECHNOLOGIES, For: Apr 17 -4.7%
3/4 Form DEFA14A AGILENT TECHNOLOGIES, -4.6%
3/18 Agilent Technologies Announces Cash Dividend of 18 Cents Per Share -4.5%
2/24 Agilent Technologies Inc (NYSE: A) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating. -4.2%
5/7 Agilent Announces Unique Portfolio to Advance Immunotherapy -3.4%
1/29 Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics -3.3%
4/30 Agilent Technologies Inc (NYSE: A) had its price target lowered by analysts at Cfra from $57.00 to $39.00. They now have a "hold" rating on the stock. -3.2%
8/9 Agilent Technologies Hitting Lower Rail Of Upwardly Sloped Trend Channel Ahead Of Earnings [Seeking Alpha] -2.9%
7/11 Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: